Skip to content
Parker Institute for Cancer Immunotherapy
Search
Search Close

Cécile Alanio, MD, PhD

Parker Bridge Fellow

Biography

Cécile is a former postdoc in the Wherry Lab at the University of Pennsylvania. During her postdoc, she worked on samples from COVID patients, as well as PDAC, glioblastoma, lymphoma and CAR T cancer patients with a translational approach. She is now deputy director of the Clinical Immunology Laboratory at Institut Curie in Paris, France, where she helps coordinate the immunomonitoring of cancer patients. Cécile also is a Parker Bridge Scholar in the independent phase in the U932 (Amigorena team). Her T Cell Inspection (TCI) team studies T-cell biology in human health and disease. Her focus is on solid tumors and CAR T-cell profiling. Cécile is an active collaborator of the Wherry Lab the and the Parker Institute for Cancer Immunotherapy (PICI).

Education & Training

  • 2011: Université Paris 5, Paris, France, MD, Medicine
  • 2015: Institut Pasteur, Paris, France, Ph.D., Immunology

Awards & Honors

  • 2019: Parker Bridge Fellow
  • 2018: Philippe Foundation Award
  • 2017 : Institut National Cancer Association, support for training young doctors in translational research in oncology (Postdoc)
  • 2017: Fondation Bettencourt Schueller Young Researcher Award
  • 2017: Project granted with Seal of Excellence at EU H2020 Marie Curie Individual (Global) Fellowship (TURBO project)
  • 2016: Awarded among the 300 best talents 2016 L’Oréal-UNESCO Pour les Femmes et la Science
  • 2011: Institut National Cancer Association, support for training young doctors in translational research in oncology (PhD)
  • 2008: Institut National Cancer Association, support for training young doctors in translational research in oncology (Master)